Microvessel density, expression of proto-oncogenes, resistance-related proteins and incidence of metastases in primary ovarian carcinomas

Clinical and Experimental Metastasis

Volumn 14, Issue 3, 1996, Pages 209-214

  Volm, Manfred ^a,b   Koomägi, Reet ^a,c   Kaufmann, Manfred ^a   Mattern, Jürgen ^a   Stammler, Gerd ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^c UNIVERSITY OF TARTU   (Estonia)

Author keywords

Metastasis; Microvessel density; Ovarian carcinoma; Proto oncogenes; Resistance related proteins

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; METASTASIS POTENTIAL; MICROVASCULATURE; ONCOGENE C JUN; ONCOGENE C MYC; OVARY CARCINOMA; PROTEIN SYNTHESIS REGULATION; PROTO ONCOGENE;

ADOLESCENT; ADULT; AGED; CARCINOMA; DRUG RESISTANCE, NEOPLASM; FEMALE; GENES, ERBB-1; GENES, JUN; GENES, MYC; GLUTATHIONE TRANSFERASE; HSP70 HEAT-SHOCK PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROCIRCULATION; MIDDLE AGED; NEOPLASM METASTASIS; OVARIAN NEOPLASMS; P-GLYCOPROTEIN; PROTO-ONCOGENE PROTEINS; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 0030017822     PISSN: 02620898     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Poste G and Fidler, IJ, 1980, The pathogenesis of cancer metastasis. Nature, 283, 139-46.
2. Nicolson GL, 1984, Tumor progression, oncogenes and the evolution of metastatic phenotypic diversity. Clin Exp Metastasis, 2, 85-105.
3. Volm M, Drings P, Wodrich W and van Kaick G, 1993, Expression of onco-proteins in primary human non-small cell lung cancer and incidence of metastases. Clin Exp Metastasis, 11, 325-9.
4. Weidner N, Corroll PR, Flax J, Blumenfeld W and Folkman J, 1993, Tumor angiogenesis correlates with metastasis in invasive prostate carcinoma. Am J Pathol, 143, 401-9.
5. Volm M, Bak M, Efferth T, Lathan B and Mattern J, 1988, Immunocytochemical detection of a resistance-associated glycoprotein in tissue culture cells, ascites tumors and human tumor xenografts by Mab 265/F4. Anticancer Res, 8, 531-6.
6. Volm M, Kästel M, Mattern J and Efferth T. 1993, Expression of resistance factors (P-glycoprotein. glutathione S-transferase-π and topoisomerase II) and their interrelationship to proto-oncogene products in renal cell carcinoma. Cancer, 71, 3981-7.
7. Weidner N, 1995. Intratumor microvessel density as a prognostic factor in cancer. Am J Pathol, 147, 9-19.
8. Bosari S, Lee AK, DeLellis RA, Wiley BD, Heatley GJ and Silverman ML, 1992, Microvessel quantitation and prognosis in invasive breast carcinoma. Hum Pathol, 23, 755-61.
9. Weidner N, Semple JB, Welch WR and Folkman J, 1991, Tumor angiogenesis and metastasis. Correlation in invasive breast carcinoma. New Engl J Med, 324, 1-8.
10. Maeda K, Chung YS, Takatsuka S, et al. 1995, Tumor angiogenesis as a predictor of recurrence in gastric carcinoma. J Clin Oncol, 13, 477-81.
11. Olivarez D, Ulbright T, DeRiese W, et al. 1994. Neovascularization in clinical stage I testicular germ cell tumor: prediction of metastatic disease. Cancer Res, 54, 2800-2.
12. Welch DR, Bisi JE, Miller BE, et al. 1991, Characterization of a highly invasive and spontaneously metastatic human malignant melanoma cell line. Int J Cancer, 47, 227-37.
13. Sato K, Miyahara M, Saito T and Kobayashi M, 1994, C-myc mRNA overexpression is associated with lymph node metastasis in colorectal cancer. Eur J Cancer, 30, 1113-17.
14. Fontanini G, Vignati S, Bigini D, et al. 1995, Epidermal growth factor (EGFR) expression in non-small cell lung carcinomas correlates with metastatic involvement of hilar and mediastinal lymph nodes in the squamous subtype. Eur J Cancer, 31, 178-83.
15. Fujino S, Enokibori T, Katsura A, et al. 1994, Relationship between epidermal growth factor receptor expression and various prognostic factors in human non-small cell lung cancer. Lung Cancer - Japan, 34, 89-94.
16. Diez M, Maestro ML, Torres A, et al. 1994, Epidermal growth factor receptor in non-small cell cancer of the lung. Arch Broncopneumol, 30, 282-6.
17. Khalifa MA, Manuel RS, Haraway SD, Walker J and Min KW, 1994, Expression of EGFR, HER-2/neu, p53, and PCNA in endometrioid, serous papillary, and clear cell endometrial adenocarcinomas. Gvnecol Oncol, 53, 84-92.
18. Castellani R, Visscher DW, Wykes S, Sarkar FH and Crissman JD, 1994, Interaction of transforming growth factor-alpha and epidermal growth factor receptor in breast carcinoma: an immunohistologic study. Cancer, 73, 344-9.
19. Toi M, Tominga T, Osaki A and Toge T, 1994, Role of epidermal growth factor receptor expression in primary breast cancer: results of a biochemical study and an immunocytochemical study. Breast Cancer Res Treat, 29, 51-8.
20. Shtil A, Shushanow A, Moynova E and Stavrovskaya A, 1994, Frequency of metastasis in Syrian hamster tumor cells selected for low level of "typical" multidrug resistance. Exp Toxicol Pathol, 46, 257-62.
21. Riordan JR and Ling V, 1985, Genetic and biochemical characterisation of multidrug resistance. Pharmacol Ther, 28, 51-7.
22. Volm M, Mattern J and Samsel B, 1992, Relationship of inherent resistance to doxorubicin, proliferative activity and expression of P-glycoprotein 170 and glutathione S-transferase-π in human lung tumors. Cancer, 70, 764-9.
23. Volm M, Mattern J, Efferth T and Pommerenke EW, 1992, Expression of several resistance mechanisms in untreated human kidney and lung carcinomas. Anticancer Res, 12, 1063-8.
24. Morrow CS and Cowan K, 1990, Glutathione S-transferase and drug resistance. Cancer Cells, 2, 15-22.
25. Ciocca DR, Clark GM, Tandon AK, Fuqua SAW, Welch WJ and McGuire WL, 1993, Heat shock protein hsp 70 in patients with axillary lymph node-negative breast cancer: prognostic implications. J Natl Cancer Inst, 85, 570-4.
26. Huot J, Roy G, Lambert H, Chretien P and Landry J, 1991, Increased survival after treatments with anticancer agents of Chinese hamster cells expressing the human Mr 27,000 heat shock protein. Cancer Res, 51, 245-52.
27. Volm M, Koomägi R, Mattern J and Stammler G, 1995, Heat shock (hsp 70) and resistance proteins in non-small cell lung carcinomas. Cancer Lett, 95, 195-200.